American Well Corporation

NYSE:AMWL

Medical - Healthcare Information Services

Healthcare
$11.03 +2.82%

+$0.24 today

Market cap
$171.77M
Beta
1.70
P/E (TTM)
-1.6
EPS (TTM)
-$5.30
52W Low $3.71High $9.96

Volume 0.06M

Average 0.07M

AMWL Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

American Well CorporationNYSE: AMWL

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures declines year over year

Q1 FY2026 capital expenditures of $5K (cash outflow) fell 44.4% year over year, ahead of the -99.9% change in trailing-twelve-month capital expenditures. Sequentially, it fell 58.3% from the prior quarter. Over 3 fiscal years it compounded at -87.4% a year.

Context

  • Capital expenditures amounted to 0.0% of revenue in FY2025, down 6.0 pp from a year earlier.
  • Capital expenditures grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -44.4% holds above the trailing-twelve-month pace of -99.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$5K-58.3% QoQ
Last fiscal yearDec 2025
-$21K-99.9% YoY
LTMMar 2026
-$17K-99.9% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-44.4%——
1 year-99.9%——
3-year CAGR-87.4%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(21K) USD
Year-over-year change
+99.9%

Capital Expenditures vs competitors

How AMWL compares with its peers on the latest reported figures

  • AMWL's LTM Mar 2026 capital expenditures of $17K is the 7th largest of the 9 companies compared; the peer median is $106.64K.
  • Its year-over-year change of -99.9% is the lowest of 9, against a peer median of -28.0%.
  • Capital expenditures amounts to 0.0% of revenue for AMWL, versus a peer median of 0.5%.
AMWL Competitors Peer median
Capital Expenditures for AMWL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ATYRaTyr Pharma, Inc.LTM Mar 2026$215K +347.9%-63.9%113.2%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$202K -43.7%-47.0%—
IMUXImmunic, Inc.LTM Mar 2026$116K -58.6%+12.9%—
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$109K -90.6%+115.1%—
EUDAEUDA Health Holdings LimitedLTM Jun 2026$104.29K -12.2%+79.2%0.9%
DTILPrecision BioSciences, Inc.LTM Mar 2026$54K -89.3%-70.5%0.1%
AMWLAmerican Well CorporationLTM Mar 2026$17K -99.9%-87.4%0.0%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$0 +100.0%—0.0%
BMEABiomea Fusion, Inc.LTM Mar 2026$0 +100.0%——
Peer median (excluding AMWL) $106.64K-28.0%-17.1%0.5%

Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(176.78M)(272.07M)(675.16M)(208.14M)(95.7M)
Depreciation & Amortization16.09M26.17M31.92M33.43M33.96M
Deferred Income Tax(6.25M)(2.52M)(242K)(243K)(1.11M)
Stock-Based Compensation43.81M67.68M72.25M47.54M22.01M
Change in Working Capital(27.72M)(28.1M)(15.51M)(9.98M)(26.8M)
Accounts Receivables(512K)(8.14M)3.25M(25.01M)12.22M
Inventory1.6M(1.21M)2.09M1.9M1.17M
Accounts Payables5.55M(4.78M)(2.36M)159K(3.42M)
Other Working Capital(34.35M)(13.97M)(18.48M)12.97M(36.77M)
Other Non-Cash Items9.31M16.53M438.4M57.6M1.68M
Operating Cash Flow(141.54M)(192.32M)(148.34M)(127.34M)(65.95M)
Capital Expenditures(559K)(10.45M)(15.25M)(15.22M)(21K)
Acquisitions (Net)(159.07M)(1.96M)0(3.43M)18.32M
Purchases of Investments2.55M(499.22M)(389.99M)0(1M)
Sales of Investments100M500M389.99M00
Other Investing Activities(2.55M)0(18.88M)(15.1M)(196K)
Investing Cash Flow(59.63M)(11.63M)(19.17M)(18.65M)17.1M
Debt Repayment00000
Common Stock Issued0000844K
Common Stock Repurchased(15.04M)(360K)(586K)(3K)(4K)
Dividends Paid00000
Other Financing Activities20.79M(3.25M)2.73M1.38M0
Financing Cash Flow5.75M(3.61M)2.15M1.38M840K
Effect of Forex Changes(84K)(305K)(1.14M)887K2.02M
Net Change in Cash(195.5M)(207.87M)(166.51M)(143.72M)(45.99M)
Free Cash Flow(142.1M)(202.77M)(163.59M)(142.56M)(65.97M)

American Well Corporation

NYSE:AMWL

Intrinsic Alpha fair value

Locked

Current Price

$11.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.